ketoconazole has been researched along with Chronic Hepatitis C in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Telaprevir is an inhibitor of the HCV NS3/4A protease." | 2.48 | Telaprevir: pharmacokinetics and drug interactions. ( Beaumont, M; Garg, V; Kauffman, RS; van Heeswijk, RP, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, V | 1 |
| Kauffman, RS | 1 |
| Beaumont, M | 1 |
| van Heeswijk, RP | 1 |
1 review available for ketoconazole and Chronic Hepatitis C
| Article | Year |
|---|---|
Telaprevir: pharmacokinetics and drug interactions.
Topics: Animals; Antiviral Agents; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A | 2012 |